Paper41999560
Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.
Chen YF and 8 others. J Gastrointest Cancer, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery. Papers, record 41999560. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999560
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Stomach Neoplasms | Major topic |
| Gastrectomy | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Humans | |
| Chemotherapy, Adjuvant | |
| Female | |
| Retrospective Studies | |
| Neoplasm Staging | |
| Male | |
| Middle Aged | |
| Aged | |
| Survival Rate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CMRPG3I0103 | Chang Gung Medical Research Program, Taiwan | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35743747 | Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery. | J Pers Med | 2022 | https://conductscience.org/library/papers/35743747 | PubMed |
| 2 | 17978289 | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17978289 | PubMed |
| 3 | 33336033 | Prognostic factors in stage I gastric cancer: A retrospective analysis. | Open Med (Wars) | 2020 | https://conductscience.org/library/papers/33336033 | PubMed |
| 4 | 30543589 | Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives. | Clin Adv Hematol Oncol | 2018 | https://conductscience.org/library/papers/30543589 | PubMed |
| 5 | 21444866 | Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21444866 | PubMed |
| 6 | 34838393 | Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm. | Eur J Surg Oncol | 2022 | https://conductscience.org/library/papers/34838393 | PubMed |
| 7 | 30404528 | Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients. | Rev Esp Enferm Dig | 2019 | https://conductscience.org/library/papers/30404528 | PubMed |
| 8 | 16822992 | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16822992 | PubMed |
| 9 | 22226517 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. | Lancet | 2012 | https://conductscience.org/library/papers/22226517 | PubMed |
| 10 | 34075484 | Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/34075484 | PubMed |
| 11 | 34019698 | Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group. | Int J Cancer | 2021 | https://conductscience.org/library/papers/34019698 | PubMed |
| 12 | 20409751 | Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/20409751 | PubMed |
| 13 | 39566657 | A comprehensive overview of gastric cancer management from a surgical point of view. | Biomed J | 2025 | https://conductscience.org/library/papers/39566657 | PubMed |
| 14 | 35969830 | Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/35969830 | PubMed |
| 15 | 36342574 | Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). | Gastric Cancer | 2023 | https://conductscience.org/library/papers/36342574 | PubMed |
| 16 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 17 | 27090793 | Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States. | Ann Surg Oncol | 2016 | https://conductscience.org/library/papers/27090793 | PubMed |
| 18 | 39822170 | Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline). | J Gastric Cancer | 2025 | https://conductscience.org/library/papers/39822170 | PubMed |
| 19 | 30903518 | Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis. | Clin Transl Oncol | 2019 | https://conductscience.org/library/papers/30903518 | PubMed |
| 20 | 33024588 | Prognostic Factors in Stage IB Gastric Cancer after Surgical Resection. | J Gastric Cancer | 2020 | https://conductscience.org/library/papers/33024588 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41999560
GET https://conductscience.org/api/papers/v1/41999560/references?page=2